• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Aug 19
8:00 am - 9:00 am EDT

Member Forum: Equitable Access to Care

Aug 19
6:00 pm - 7:00 pm EDT

Member Forum: Equitable Access to Care

Aug 20
11:00 am - 12:00 pm EDT

ALS-FTD Clinicopathological Overlap

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy

View Calendar

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Susan Keldani, USA

    Susan Keldani, USA

  • Daniel Hare, USA

    Daniel Hare, USA

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Anna Barrow, UK

    Anna Barrow, UK

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Torben Mikkelsen, Denmark

    Torben Mikkelsen, Denmark

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Bayley, Australia

    Bayley, Australia

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Willi Klein, UK

    Willi Klein, UK

  • Debbie Craghill, USA

    Debbie Craghill, USA

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Yessenia Hernandez Mendoza, Mexico

    Yessenia Hernandez Mendoza, Mexico

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • John Dinon, Australia

    John Dinon, Australia

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Denis Blais, Canada

    Denis Blais, Canada

  • Steve

    Steve

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login